Hjem › Immunforsvar og lidelser › Oregon › Portland
Kliniske studier for Immunforsvar og lidelser i Portland, OR
9 studier for Immunforsvar og lidelser søker deltakere på steder i og rundt Portland (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
RekruttererFase 1
- Oregon Health & Science University, Portland
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RekruttererFase 3
- Oregon Health & Science University, Portland
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
RekruttererObservasjonsstudie
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Portland VA Medical Center, Portland
- og 1 flere
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RekruttererFase 3
- Oregon Health & Science University, Portland
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
RekruttererFase 1
- Providence Portland Medical Center, Portland
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
RekruttererFase 2
- Inmagene Site 3, Portland
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
RekruttererFase 2
- Oregon Health and Science University, Portland
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
RekruttererFase 1/2
- Providence Neurological Specialties West, Portland
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
RekruttererFase 2
- Oregon Health and Science University, Portland
Immunforsvar og lidelser-studier i andre byer
- Washington, DC13 studier
- New York City, NY12 studier
- Boston, MA10 studier
- Philadelphia, PA10 studier
- Atlanta, GA9 studier
- Houston, TX9 studier
- Chicago, IL8 studier
- Los Angeles, CA8 studier
- Cleveland, OH8 studier
- Seattle, WA6 studier
- Milwaukee, WI6 studier
- Cedar Rapids, IA6 studier
Andre studier i Portland
- Ikke-småcellet lungekreft46 studier
- Kreft (alle typer)34 studier
- Prostatakreft33 studier
- Brystkreft33 studier
- Metastatisk kreft29 studier
- Kolorektal kreft28 studier
- Eggstokkreft27 studier
- Lungekreft26 studier
- Akut myelogen leukemi25 studier
- Endometriekreft24 studier
- Plateepitelcancer i hode og hals19 studier
- Pankreaskreft19 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.